Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis

Andrographolide (AD) has been reported to play a potential anti-arthritic role by facilitating the proliferation and inhibiting the apoptosis of chondrocytes. However, the molecular mechanism underlying the protective role of AD in osteoarthritis (OA) remains to be elucidated. OA mice model was esta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant immunology 2022-04, Vol.71, p.101548-101548, Article 101548
Hauptverfasser: Yan, Wei, Yu, Hong, Liu, Bo, Jiang, Zewei, Jin, Hailong, Li, Zhiheng, Li, Lei, Zou, Debao, Jiang, Hongjiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101548
container_issue
container_start_page 101548
container_title Transplant immunology
container_volume 71
creator Yan, Wei
Yu, Hong
Liu, Bo
Jiang, Zewei
Jin, Hailong
Li, Zhiheng
Li, Lei
Zou, Debao
Jiang, Hongjiang
description Andrographolide (AD) has been reported to play a potential anti-arthritic role by facilitating the proliferation and inhibiting the apoptosis of chondrocytes. However, the molecular mechanism underlying the protective role of AD in osteoarthritis (OA) remains to be elucidated. OA mice model was established via anterior cruciate ligament transection (ACLT) operation. OA cell model was established through treating mice primary chondrocytes with LPS (1 μg/mL, 24 h). Enzyme-linked immunosorbent assay (ELISA) was performed to measure the concentrations of inflammatory cytokines in the supernatant. Cell proliferation was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-Ethynyl-2′-deoxyuridine (EdU) assay. Cell apoptosis was evaluated by flow cytometry. The intermolecular interaction was verified by dual-luciferase reporter assay. AD administration reduced the infiltration of inflammatory cells in the synovial tissues of ankle joint and suppressed the inflammatory response in OA mice model in vivo. Lipopolysaccharide (LPS) stimulation suppressed the proliferation and induced the apoptosis and inflammation of chondrocytes, and AD treatment protected chondrocytes from LPS-induced dysfunction. Circular RNA (circRNA) Rap guanine nucleotide exchange factor 1 (circ_Rapgef1) overexpression attenuated AD-mediated protective effects in OA cell model. Circ_Rapgef1/microRNA-383-3p (miR-383-3p)/Nod-like receptor pyrin domain 3 (NLRP3) axis was identified in this study for the first time. Circ_Rapgef1 overexpression-mediated effects were partly reversed by the overexpression of miR-383-3p in chondrocytes. NLRP3 silencing partly overturned miR-383-3p knockdown-mediated effects in chondrocytes. Circ_Rapgef1 overexpression up-regulated the expression of NLRP3 partly by targeting miR-383-3p in chondrocytes. Circ_Rapgef1 suppressed AD-mediated protective effects in OA partly by regulating miR-383-3p/NLRP3 signaling.
doi_str_mv 10.1016/j.trim.2022.101548
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2626002794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966327422000223</els_id><sourcerecordid>2626002794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-947425aa99c7a5aeba984f49a41569b16cf02a114e0d37f81d69d016c9f6ee133</originalsourceid><addsrcrecordid>eNp9kE1r20AQhpfSULtp_0APRcdeZO-3tNBLCEkaMEkw6XlZr0byGllSd6QQ__uscNpjTwMzz7zMPIR8Y3TFKNPrw2qM4bjilPO5oWT5gSxZWZS5koZ_JEtqtM4FL-SCfEY8UEq5MsUnshCKcW5UsSTDVVfFvolu2PdtqCDDaRgiIAJmPY7QuzjuYxgDZsPMpUnou2x3yiI0U-vG0DWZD9HbrRsaqNn6GLa5KEUuhvXDZvskMgxN59qZc68Bv5CL2rUIX9_rJfl9e_N8_SvfPN7dX19tci-UHnMjC8mVc8b4wikHO2dKWUvjJFPa7Jj2NeWOMQm0EkVdskqbKknxptYATIhL8uOcm87-MwGO9hjQQ9u6DvoJLddcJx-FkQnlZ9THHjFCbYfk1cWTZdTOpu3BzqbtbNqeTael7-_50-4I1b-Vv2oT8PMMQPryJUC06AN0HqoQwY-26sP_8t8AN5yQbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626002794</pqid></control><display><type>article</type><title>Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yan, Wei ; Yu, Hong ; Liu, Bo ; Jiang, Zewei ; Jin, Hailong ; Li, Zhiheng ; Li, Lei ; Zou, Debao ; Jiang, Hongjiang</creator><creatorcontrib>Yan, Wei ; Yu, Hong ; Liu, Bo ; Jiang, Zewei ; Jin, Hailong ; Li, Zhiheng ; Li, Lei ; Zou, Debao ; Jiang, Hongjiang</creatorcontrib><description>Andrographolide (AD) has been reported to play a potential anti-arthritic role by facilitating the proliferation and inhibiting the apoptosis of chondrocytes. However, the molecular mechanism underlying the protective role of AD in osteoarthritis (OA) remains to be elucidated. OA mice model was established via anterior cruciate ligament transection (ACLT) operation. OA cell model was established through treating mice primary chondrocytes with LPS (1 μg/mL, 24 h). Enzyme-linked immunosorbent assay (ELISA) was performed to measure the concentrations of inflammatory cytokines in the supernatant. Cell proliferation was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-Ethynyl-2′-deoxyuridine (EdU) assay. Cell apoptosis was evaluated by flow cytometry. The intermolecular interaction was verified by dual-luciferase reporter assay. AD administration reduced the infiltration of inflammatory cells in the synovial tissues of ankle joint and suppressed the inflammatory response in OA mice model in vivo. Lipopolysaccharide (LPS) stimulation suppressed the proliferation and induced the apoptosis and inflammation of chondrocytes, and AD treatment protected chondrocytes from LPS-induced dysfunction. Circular RNA (circRNA) Rap guanine nucleotide exchange factor 1 (circ_Rapgef1) overexpression attenuated AD-mediated protective effects in OA cell model. Circ_Rapgef1/microRNA-383-3p (miR-383-3p)/Nod-like receptor pyrin domain 3 (NLRP3) axis was identified in this study for the first time. Circ_Rapgef1 overexpression-mediated effects were partly reversed by the overexpression of miR-383-3p in chondrocytes. NLRP3 silencing partly overturned miR-383-3p knockdown-mediated effects in chondrocytes. Circ_Rapgef1 overexpression up-regulated the expression of NLRP3 partly by targeting miR-383-3p in chondrocytes. Circ_Rapgef1 suppressed AD-mediated protective effects in OA partly by regulating miR-383-3p/NLRP3 signaling.</description><identifier>ISSN: 0966-3274</identifier><identifier>EISSN: 1878-5492</identifier><identifier>DOI: 10.1016/j.trim.2022.101548</identifier><identifier>PMID: 35122957</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Andrographolide ; Animals ; Apoptosis ; circ_Rapgef1 ; Diterpenes ; Lipopolysaccharides - pharmacology ; LPS ; Mice ; MicroRNAs - genetics ; miR-383-3p ; NLR Family, Pyrin Domain-Containing 3 Protein - genetics ; NLR Proteins ; NLRP3 ; Osteoarthritis ; Osteoarthritis - drug therapy ; Pyrin Domain</subject><ispartof>Transplant immunology, 2022-04, Vol.71, p.101548-101548, Article 101548</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-947425aa99c7a5aeba984f49a41569b16cf02a114e0d37f81d69d016c9f6ee133</citedby><cites>FETCH-LOGICAL-c356t-947425aa99c7a5aeba984f49a41569b16cf02a114e0d37f81d69d016c9f6ee133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0966327422000223$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35122957$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Wei</creatorcontrib><creatorcontrib>Yu, Hong</creatorcontrib><creatorcontrib>Liu, Bo</creatorcontrib><creatorcontrib>Jiang, Zewei</creatorcontrib><creatorcontrib>Jin, Hailong</creatorcontrib><creatorcontrib>Li, Zhiheng</creatorcontrib><creatorcontrib>Li, Lei</creatorcontrib><creatorcontrib>Zou, Debao</creatorcontrib><creatorcontrib>Jiang, Hongjiang</creatorcontrib><title>Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis</title><title>Transplant immunology</title><addtitle>Transpl Immunol</addtitle><description>Andrographolide (AD) has been reported to play a potential anti-arthritic role by facilitating the proliferation and inhibiting the apoptosis of chondrocytes. However, the molecular mechanism underlying the protective role of AD in osteoarthritis (OA) remains to be elucidated. OA mice model was established via anterior cruciate ligament transection (ACLT) operation. OA cell model was established through treating mice primary chondrocytes with LPS (1 μg/mL, 24 h). Enzyme-linked immunosorbent assay (ELISA) was performed to measure the concentrations of inflammatory cytokines in the supernatant. Cell proliferation was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-Ethynyl-2′-deoxyuridine (EdU) assay. Cell apoptosis was evaluated by flow cytometry. The intermolecular interaction was verified by dual-luciferase reporter assay. AD administration reduced the infiltration of inflammatory cells in the synovial tissues of ankle joint and suppressed the inflammatory response in OA mice model in vivo. Lipopolysaccharide (LPS) stimulation suppressed the proliferation and induced the apoptosis and inflammation of chondrocytes, and AD treatment protected chondrocytes from LPS-induced dysfunction. Circular RNA (circRNA) Rap guanine nucleotide exchange factor 1 (circ_Rapgef1) overexpression attenuated AD-mediated protective effects in OA cell model. Circ_Rapgef1/microRNA-383-3p (miR-383-3p)/Nod-like receptor pyrin domain 3 (NLRP3) axis was identified in this study for the first time. Circ_Rapgef1 overexpression-mediated effects were partly reversed by the overexpression of miR-383-3p in chondrocytes. NLRP3 silencing partly overturned miR-383-3p knockdown-mediated effects in chondrocytes. Circ_Rapgef1 overexpression up-regulated the expression of NLRP3 partly by targeting miR-383-3p in chondrocytes. Circ_Rapgef1 suppressed AD-mediated protective effects in OA partly by regulating miR-383-3p/NLRP3 signaling.</description><subject>Andrographolide</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>circ_Rapgef1</subject><subject>Diterpenes</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>LPS</subject><subject>Mice</subject><subject>MicroRNAs - genetics</subject><subject>miR-383-3p</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</subject><subject>NLR Proteins</subject><subject>NLRP3</subject><subject>Osteoarthritis</subject><subject>Osteoarthritis - drug therapy</subject><subject>Pyrin Domain</subject><issn>0966-3274</issn><issn>1878-5492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r20AQhpfSULtp_0APRcdeZO-3tNBLCEkaMEkw6XlZr0byGllSd6QQ__uscNpjTwMzz7zMPIR8Y3TFKNPrw2qM4bjilPO5oWT5gSxZWZS5koZ_JEtqtM4FL-SCfEY8UEq5MsUnshCKcW5UsSTDVVfFvolu2PdtqCDDaRgiIAJmPY7QuzjuYxgDZsPMpUnou2x3yiI0U-vG0DWZD9HbrRsaqNn6GLa5KEUuhvXDZvskMgxN59qZc68Bv5CL2rUIX9_rJfl9e_N8_SvfPN7dX19tci-UHnMjC8mVc8b4wikHO2dKWUvjJFPa7Jj2NeWOMQm0EkVdskqbKknxptYATIhL8uOcm87-MwGO9hjQQ9u6DvoJLddcJx-FkQnlZ9THHjFCbYfk1cWTZdTOpu3BzqbtbNqeTael7-_50-4I1b-Vv2oT8PMMQPryJUC06AN0HqoQwY-26sP_8t8AN5yQbw</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Yan, Wei</creator><creator>Yu, Hong</creator><creator>Liu, Bo</creator><creator>Jiang, Zewei</creator><creator>Jin, Hailong</creator><creator>Li, Zhiheng</creator><creator>Li, Lei</creator><creator>Zou, Debao</creator><creator>Jiang, Hongjiang</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202204</creationdate><title>Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis</title><author>Yan, Wei ; Yu, Hong ; Liu, Bo ; Jiang, Zewei ; Jin, Hailong ; Li, Zhiheng ; Li, Lei ; Zou, Debao ; Jiang, Hongjiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-947425aa99c7a5aeba984f49a41569b16cf02a114e0d37f81d69d016c9f6ee133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Andrographolide</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>circ_Rapgef1</topic><topic>Diterpenes</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>LPS</topic><topic>Mice</topic><topic>MicroRNAs - genetics</topic><topic>miR-383-3p</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - genetics</topic><topic>NLR Proteins</topic><topic>NLRP3</topic><topic>Osteoarthritis</topic><topic>Osteoarthritis - drug therapy</topic><topic>Pyrin Domain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yan, Wei</creatorcontrib><creatorcontrib>Yu, Hong</creatorcontrib><creatorcontrib>Liu, Bo</creatorcontrib><creatorcontrib>Jiang, Zewei</creatorcontrib><creatorcontrib>Jin, Hailong</creatorcontrib><creatorcontrib>Li, Zhiheng</creatorcontrib><creatorcontrib>Li, Lei</creatorcontrib><creatorcontrib>Zou, Debao</creatorcontrib><creatorcontrib>Jiang, Hongjiang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Wei</au><au>Yu, Hong</au><au>Liu, Bo</au><au>Jiang, Zewei</au><au>Jin, Hailong</au><au>Li, Zhiheng</au><au>Li, Lei</au><au>Zou, Debao</au><au>Jiang, Hongjiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis</atitle><jtitle>Transplant immunology</jtitle><addtitle>Transpl Immunol</addtitle><date>2022-04</date><risdate>2022</risdate><volume>71</volume><spage>101548</spage><epage>101548</epage><pages>101548-101548</pages><artnum>101548</artnum><issn>0966-3274</issn><eissn>1878-5492</eissn><abstract>Andrographolide (AD) has been reported to play a potential anti-arthritic role by facilitating the proliferation and inhibiting the apoptosis of chondrocytes. However, the molecular mechanism underlying the protective role of AD in osteoarthritis (OA) remains to be elucidated. OA mice model was established via anterior cruciate ligament transection (ACLT) operation. OA cell model was established through treating mice primary chondrocytes with LPS (1 μg/mL, 24 h). Enzyme-linked immunosorbent assay (ELISA) was performed to measure the concentrations of inflammatory cytokines in the supernatant. Cell proliferation was assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-Ethynyl-2′-deoxyuridine (EdU) assay. Cell apoptosis was evaluated by flow cytometry. The intermolecular interaction was verified by dual-luciferase reporter assay. AD administration reduced the infiltration of inflammatory cells in the synovial tissues of ankle joint and suppressed the inflammatory response in OA mice model in vivo. Lipopolysaccharide (LPS) stimulation suppressed the proliferation and induced the apoptosis and inflammation of chondrocytes, and AD treatment protected chondrocytes from LPS-induced dysfunction. Circular RNA (circRNA) Rap guanine nucleotide exchange factor 1 (circ_Rapgef1) overexpression attenuated AD-mediated protective effects in OA cell model. Circ_Rapgef1/microRNA-383-3p (miR-383-3p)/Nod-like receptor pyrin domain 3 (NLRP3) axis was identified in this study for the first time. Circ_Rapgef1 overexpression-mediated effects were partly reversed by the overexpression of miR-383-3p in chondrocytes. NLRP3 silencing partly overturned miR-383-3p knockdown-mediated effects in chondrocytes. Circ_Rapgef1 overexpression up-regulated the expression of NLRP3 partly by targeting miR-383-3p in chondrocytes. Circ_Rapgef1 suppressed AD-mediated protective effects in OA partly by regulating miR-383-3p/NLRP3 signaling.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35122957</pmid><doi>10.1016/j.trim.2022.101548</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0966-3274
ispartof Transplant immunology, 2022-04, Vol.71, p.101548-101548, Article 101548
issn 0966-3274
1878-5492
language eng
recordid cdi_proquest_miscellaneous_2626002794
source MEDLINE; Elsevier ScienceDirect Journals
subjects Andrographolide
Animals
Apoptosis
circ_Rapgef1
Diterpenes
Lipopolysaccharides - pharmacology
LPS
Mice
MicroRNAs - genetics
miR-383-3p
NLR Family, Pyrin Domain-Containing 3 Protein - genetics
NLR Proteins
NLRP3
Osteoarthritis
Osteoarthritis - drug therapy
Pyrin Domain
title Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1/miR-383-3p/NLRP3 signaling axis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A35%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Andrographolide%20suppresses%20osteoarthritis%20progression%20by%20regulating%20circ_Rapgef1/miR-383-3p/NLRP3%20signaling%20axis&rft.jtitle=Transplant%20immunology&rft.au=Yan,%20Wei&rft.date=2022-04&rft.volume=71&rft.spage=101548&rft.epage=101548&rft.pages=101548-101548&rft.artnum=101548&rft.issn=0966-3274&rft.eissn=1878-5492&rft_id=info:doi/10.1016/j.trim.2022.101548&rft_dat=%3Cproquest_cross%3E2626002794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2626002794&rft_id=info:pmid/35122957&rft_els_id=S0966327422000223&rfr_iscdi=true